Timely and accurate diagnosis is the bedrock to stop misuse and overuse of medicines
|
Shobha Shukla (CNS)
Drug-resistant disease-causing microbes can infect any one of us. Bhakti Chavan, a promising bio-technologist, who never had TB before, got infected with extensively drug-resistant TB (XDR-TB) bacteria. XDR-TB is one of the most serious forms of TB. After some delay, an accurate XDR-TB diagnosis helped her access the right treatment, thanks to an MSF clinic. With steely resolve and grit, she went through the difficult treatment of XDR-TB and got cured. Not only has she defeated XDR-TB, but she also champions the cause of helping those who are fighting TB as well as drug resistance or antimicrobial resistance world- wide.
Bhakti got the WHO recommended molecular test diagnosis. But 79% of people with TB disease in India are not diagnosed on WHO recommended molecular test, but through sputum microscopy which under performs in diagnosing TB (as per India TB Report 2024). That is why WHO has called upon all the countries to completely replace microscopy with upfront molecular tests for TB diagnosis by 2027. All world leaders re-echoed this call for 100% upfront molecular test diagnosis at the UN General Assembly High Level Meeting on TB last year.
Unless we ensure that timely and accurate diagnosis for TB and all other diseases is a reality on the ground, how will we stop misuse or overuse of medicines and prevent anti- microbial resistance?
People-centred diagnostics, treatment and care is key
Even though they face the brunt of it, most people have very little understanding and awareness about antimicrobial resistance (AMR). Bhakti Chavan blames it on the lack of people-centred responses to address AMR.
Bhakti, who has done her post graduation in Biotechnology and currently works with a biotech company, says that, "Many countries have National Action Plans to address AMR, but the ground level realities are very different. Take for example TB. Despite India having a National Strategic Plan to end TB (2017-2025), there are many gaps in TB care- like shortage of medicines, restricted access to novel medicines, diagnostic delays due to non- accessibility of molecular tests. All these act as roadblocks for the underpri- vileged in accessing the best of diagnostics and treatment. Our public health programmes must ensure that the best possible care is available to all those in need, and also ensure prevention of spread of infection. So patient-centred diagnostics (including up-front drug sensitivity testing), treatment and care is most important to combat AMR."
Bhakti is one of the 12 members of the World Health Organization (WHO) Task Force of AMR Survivors, which consists of persons who have survived drug-resistant infections or have cared for those with such infections. It was established by the WHO with the aim to humanise the narrative around AMR. Bhakti wants more such committees or task forces to be formed at national level so that more survivors can join them to create awareness and literacy around AMR and help in combating it.
Antimicrobial resistance
The world is abuzz with the ever increasing menace of AMR which is listed among the top 10 global health threats, and kills more people than TB, HIV or malaria combined. The year 2024 is particularly an important one for the global response to AMR, with the UN General Assembly (UNGA) High Level Meeting on AMR due to take place on 26 September 2024 in New York.
Dr Sangeeta Sharma, Professor Head, Department of Neuro psychopharmacology, Institute of Human Behaviour and Allied Sciences (IHBAS) and President of Delhi Society for Promotion of Rational Use of Drugs, calls for coordinated efforts that are focused on diagnostic stewardship, antimicrobial ste- wardship and infection prevention and control, to deal with this manmade crisis.
But for the layperson (who is at the receiving end of this threat) what do these medicalised terms mean?
What do words like ‘antimicrobials’ and ‘antimicrobial resistance’ signify?
To put it simply, antimicrobials are medicines that are used to treat and prevent infections in humans, animals and plants by killing the germs (or pathogens) - like bacteria, parasites, viruses and fungi- that cause these infections. However, the germs fight back and, over a period of time, some of them become resistant to these medicines, making them ineffective. In scientific language we call this phenomenon antimicrobial resistance (AMR) - meaning the microbes or the disease causing germs have become resistant to the drugs and no longer get killed or destroyed by them. So treatments become less effective (or ineffective) and infections persist, spreading to other people too.
AMR is a natural phenomenon, as the pathogens evolve over time to evade their enemy- the antimicrobials. However the process is hastened and escalated by overuse and misuse of antimicrobials in humans, animals and crops. We cannot stop this phenomenon, but we can definitely slow down the process, in the interest of one and all.
A report in The Lancet estimated that drug-resistant bacterial infections alone were directly responsible for 1.27 million deaths in 2019. And 20% of these deaths were in children under 5 years.
Antimicrobials (that include antibiotics, antivirals, anti parasitics, antifungals) target specific pathogens. They are not directed against specific body conditions- like diabetes, hyper- tension, calcium deficiency, etc. Thus they are very different from analgesics, antipyretics or blood pressure control pills, and need to be handled with care, explains Dr Sharma.
Multi-pronged approach to control AMR
We can control AMR by implementing the triple shield strategy comprising:
(i) Timely and accurate diagnosis to avoid unnecessary use of antimicrobials (called Diagnostic Stewardship);
(ii) Appropriate and rational use of antimicrobials (including antibiotics), to improve treatment outcomes, reduce antimicrobial resistance, and decrease the spread of infections caused by drug-resistant organisms (called Antimicrobial Stewardship); and
(iii) Reducing spread of infections by practicing hygiene and other infection control methods (called Infection Prevention and Control).
While the onus of implementing diagnostic steward- ship and antimicrobial stewardship lies largely with the healthcare facilities, the public and medical fraternity are equal partners in implementing infection control measures.
Correct diagnosis is the foundation for initiating effective treatment
Diagnostics stewardship involves the various stages of microbiological diagnosis to identify the infection causing pathogen and to do its culture and sensitivity testing to find whether it will respond to X, Y or Z antibiotic or not.
Dr Sharma calls diagnostic stewardship the roadway to antimicrobial stewardship: "It is an important first step that helps in doing the right testing for the right patient at the right time, so that appropriate decisions can be taken for the management of the infection. Antimicrobial misuse is driven by diagnostic uncertainties. We have very good molecular and rapid diagnostic tests available for many diseases.
(To be contd)
Drug-resistant disease-causing microbes can infect any one of us. Bhakti Chavan, a promising bio-technologist, who never had TB before, got infected with extensively drug-resistant TB (XDR-TB) bacteria. XDR-TB is one of the most serious forms of TB. After some delay, an accurate XDR-TB diagnosis helped her access the right treatment, thanks to an MSF clinic. With steely resolve and grit, she went through the difficult treatment of XDR-TB and got cured. Not only has she defeated XDR-TB, but she also champions the cause of helping those who are fighting TB as well as drug resistance or antimicrobial resistance world- wide.
Bhakti got the WHO recommended molecular test diagnosis. But 79% of people with TB disease in India are not diagnosed on WHO recommended molecular test, but through sputum microscopy which under performs in diagnosing TB (as per India TB Report 2024). That is why WHO has called upon all the countries to completely replace microscopy with upfront molecular tests for TB diagnosis by 2027. All world leaders re-echoed this call for 100% upfront molecular test diagnosis at the UN General Assembly High Level Meeting on TB last year.
Unless we ensure that timely and accurate diagnosis for TB and all other diseases is a reality on the ground, how will we stop misuse or overuse of medicines and prevent anti- microbial resistance?
People-centred diagnostics, treatment and care is key
Even though they face the brunt of it, most people have very little understanding and awareness about antimicrobial resistance (AMR). Bhakti Chavan blames it on the lack of people-centred responses to address AMR.
Bhakti, who has done her post graduation in Biotechnology and currently works with a biotech company, says that, "Many countries have National Action Plans to address AMR, but the ground level realities are very different. Take for example TB. Despite India having a National Strategic Plan to end TB (2017-2025), there are many gaps in TB care- like shortage of medicines, restricted access to novel medicines, diagnostic delays due to non- accessibility of molecular tests. All these act as roadblocks for the underpri- vileged in accessing the best of diagnostics and treatment. Our public health programmes must ensure that the best possible care is available to all those in need, and also ensure prevention of spread of infection. So patient-centred diagnostics (including up-front drug sensitivity testing), treatment and care is most important to combat AMR."
Bhakti is one of the 12 members of the World Health Organization (WHO) Task Force of AMR Survivors, which consists of persons who have survived drug-resistant infections or have cared for those with such infections. It was established by the WHO with the aim to humanise the narrative around AMR. Bhakti wants more such committees or task forces to be formed at national level so that more survivors can join them to create awareness and literacy around AMR and help in combating it.
Antimicrobial resistance
The world is abuzz with the ever increasing menace of AMR which is listed among the top 10 global health threats, and kills more people than TB, HIV or malaria combined. The year 2024 is particularly an important one for the global response to AMR, with the UN General Assembly (UNGA) High Level Meeting on AMR due to take place on 26 September 2024 in New York.
Dr Sangeeta Sharma, Professor Head, Department of Neuro psychopharmacology, Institute of Human Behaviour and Allied Sciences (IHBAS) and President of Delhi Society for Promotion of Rational Use of Drugs, calls for coordinated efforts that are focused on diagnostic stewardship, antimicrobial ste- wardship and infection prevention and control, to deal with this manmade crisis.
But for the layperson (who is at the receiving end of this threat) what do these medicalised terms mean?
What do words like ‘antimicrobials’ and ‘antimicrobial resistance’ signify?
To put it simply, antimicrobials are medicines that are used to treat and prevent infections in humans, animals and plants by killing the germs (or pathogens) - like bacteria, parasites, viruses and fungi- that cause these infections. However, the germs fight back and, over a period of time, some of them become resistant to these medicines, making them ineffective. In scientific language we call this phenomenon antimicrobial resistance (AMR) - meaning the microbes or the disease causing germs have become resistant to the drugs and no longer get killed or destroyed by them. So treatments become less effective (or ineffective) and infections persist, spreading to other people too.
AMR is a natural phenomenon, as the pathogens evolve over time to evade their enemy- the antimicrobials. However the process is hastened and escalated by overuse and misuse of antimicrobials in humans, animals and crops. We cannot stop this phenomenon, but we can definitely slow down the process, in the interest of one and all.
A report in The Lancet estimated that drug-resistant bacterial infections alone were directly responsible for 1.27 million deaths in 2019. And 20% of these deaths were in children under 5 years.
Antimicrobials (that include antibiotics, antivirals, anti parasitics, antifungals) target specific pathogens. They are not directed against specific body conditions- like diabetes, hyper- tension, calcium deficiency, etc. Thus they are very different from analgesics, antipyretics or blood pressure control pills, and need to be handled with care, explains Dr Sharma.
Multi-pronged approach to control AMR
We can control AMR by implementing the triple shield strategy comprising:
(i) Timely and accurate diagnosis to avoid unnecessary use of antimicrobials (called Diagnostic Stewardship);
(ii) Appropriate and rational use of antimicrobials (including antibiotics), to improve treatment outcomes, reduce antimicrobial resistance, and decrease the spread of infections caused by drug-resistant organisms (called Antimicrobial Stewardship); and
(iii) Reducing spread of infections by practicing hygiene and other infection control methods (called Infection Prevention and Control).
While the onus of implementing diagnostic steward- ship and antimicrobial stewardship lies largely with the healthcare facilities, the public and medical fraternity are equal partners in implementing infection control measures.
Correct diagnosis is the foundation for initiating effective treatment
Diagnostics stewardship involves the various stages of microbiological diagnosis to identify the infection causing pathogen and to do its culture and sensitivity testing to find whether it will respond to X, Y or Z antibiotic or not.
Dr Sharma calls diagnostic stewardship the roadway to antimicrobial stewardship: "It is an important first step that helps in doing the right testing for the right patient at the right time, so that appropriate decisions can be taken for the management of the infection. Antimicrobial misuse is driven by diagnostic uncertainties. We have very good molecular and rapid diagnostic tests available for many diseases.
(To be contd)